These effects may be more pronounced in older people, as age-related loss of collagen and elastin can make the skin less able to adapt to rapid changes
Three branded semaglutide products currently exist: Ozempic (injection, 0.25 mg to 2 mg weekly) for type 2 diabetes and cardiovascular risk reduction Wegovy (injection, up to 2.4 mg weekly) for long-term weight management in obese or overweight adults Rybelsus (oral tablet, 3 mg to 14 mg daily) for type 2 diabetes Compounded semaglutide, which some U.S
placebo in addition to standard-of-care
Discuss with your prescriber before any significant trip particularly if you're still in dose escalation
For labs building cardiometabolic models, Semaglutide is the GLP-1 monoagonist with the most complete cardiovascular evidence dataset across both diabetic and non-diabetic populations.
Real people are answering, not bots